Oritavancin

From IDWiki

Revision as of 20:09, 31 January 2020 by Aidan (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to:navigation, search

Semisynthetic lipoglycopeptide antibiotic with very long half-life

Indications

MRSA skin and soft tissue infections

Dosing

IV once a week, long-acting

Renal Dosing

Not required

Retrieved from "https://idwiki.org/index.php?title=Oritavancin&oldid=3477"

Lipoglycopeptides